External broker reports(aggregated public sources), CCZ Statton Equities

CCZ Statton Equities

CCZ is a leading Australian stockbroking firm providing stockbroking and wealth generation services to private clients and institutional investors. Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

External broker reports(aggregated public sources)

Equity Bottom-Up

<ul><li>Largely pre-announced, CGS recorded a FY22 group revenue of $45.0m, up +38% pcp, with the clinical trial segment attributing $40.3m, up +41% pcp.</li><li>Total backlog revenue at $139.1m, up +37% pcp, with a record $82.5m new contracts signed in the year.</li><li>CGS's market share of Alzheimer's disease clinical trials increased to 17% with 16 trials (13% with 12 trials in Dec-21).</li></ul><p><em>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.</em></p>

Largely pre-announced, CGS recorded a FY22 group revenue of $45.0m, up +38% pcp, with the clinical trial segment attributing $40.3m, up +41% pcp.Total backlog revenue at $139.1m, up +37% pcp, with a record $82.5m new contracts signed in the year.CGS's market share of Alzheimer's disease clinical trials increased to 17% with 16 trials (13% with 12 trials in Dec-21).Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Cogstate - Phase 3 Readouts Underpin the Next Phase of Accelerated Growth

Cogstate Ltd

Cogstate - Phase 3 Readouts Underpin the Next Phase of Accelerated Growth